RDH10 (retinol dehydrogenase 10) was originally identified from the retinal pigment epithelium and retinal Müller cells. It has retinoid oxidoreductase activity and is thought to play a role in the retinoid visual cycle. A recent study showed that RDH10 is essential for generating retinoic acid at early embryonic stages. The present study demonstrated that wild-type RDH10 catalysed both oxidation of all-trans-retinol and reduction of all-transretinal in a cofactor-dependent manner in vitro. In cultured cells, however, oxidation is the favoured reaction catalysed by RDH10. Substitution of any of the predicted key residues in the catalytic centre conserved in the RDH family abolished the enzymatic activity of RDH10 without affecting its protein level. Unlike other RDH members, however, replacement of Ser 197 , a key residue for stabilizing the substrate, by glycine and alanine did not abolish the enzymatic activity of RDH10, whereas RDH10 mutants S197C, S197T and S197V completely lost their enzymatic activity. These results suggest that the size of the residue at position 197 is critical for the activity of RDH10. Mutations of the three glycine residues (Gly 43 , Gly 47 and Gly 49 ) in the predicted cofactorbinding motif (Gly-Xaa 3 -Gly-Xaa-Gly) of RDH10 abolished its enzymatic activity, suggesting that the cofactor-binding motif is essential for its activity. Deletion of the two hydrophobic domains dissociated RDH10 from the membrane and abolished its activity. These studies identified the key residues for the activity of RDH10 and will contribute to the further elucidation of mechanism of this important enzyme.
INTRODUCTION
It is well known that retinoid (vitamin A derivative) metabolism is essential, not only for normal vision, but also for embryonic development and growth. A number of enzymes, retinoid-binding proteins and transporters are involved in modification, conversion and circulation of retinoids [1] [2] [3] . atROL (all-trans retinol; vitamin A) is bound by retinol-binding protein and transported from the liver to ocular tissues and non-ocular tissues. 11cRAL (11-cisretinal) is covalently bound to an opsin molecule and serves as a chromophore for rod and cone visual pigments. A single photon isomerizes 11cRAL to atRAL (all-trans-retinal), which triggers the activation of the phototransduction cascade and generates vision [4, 5] . Subsequently, 11cRAL is regenerated in the RPE (retinal pigment epithelium) through the retinoid visual cycle, which involves a number of enzymes and retinoid binding proteins [6, 7] . An intact visual cycle is essential for normal vision [8] .
Retinoid metabolism is also essential for the generation of RA (retinoic acid), which plays an important role in regulating development and cell differentiation [1, 2] . In certain tissues, atROL is first oxidized to atRAL, which is then oxidized to atRA (all-trans-RA) by a known enzyme, Raldh (retinaldehyde dehydrogenase). atRA is known to regulate cell differentiation, development and morphogenesis through the RA receptors or retinoid X receptors [1] [2] [3] .
RDHs (retinol dehydrogenases) are the enzymes that catalyse oxidation of retinol into retinal or reduction of retinal into retinol in a cofactor-dependent manner in both vision and retinoid signalling. The RDH activity is observed in two distinct classes of enzymes, namely RoDHs [microsomal retinol dehydrogenases (membrane-bound SDRs)] in the SDR (short-chain dehydrogenase/reductase) family and cytosolic ADHs (alcohol dehydrogenases) in the medium-chain dehydrogenase/reductase family [9] [10] [11] [12] [13] [14] [15] . More than 20 000 sequences (including species variants) of SDR have been deposited in the GenBank ® database [15] . A number of studies have been carried out to identify the functionally important residues among the highly conserved residues in the family by evaluating the impacts of mutations of the residues using site-directed mutagenesis [9, [16] [17] [18] [19] [20] [21] [22] [23] and crystal structure analyses of the SDR family members such as DADH [Drosophila (fruitfly) ADH] [24] , human 17β-HSD-1 (17β-hydroxysteroid dehydrogenase type 1) [25] and bacterial 3β/ 17β-HSD [26] . Most of the mutations of the conserved residues abolish their enzymatic activities [9, [16] [17] [18] [19] [20] [21] [22] [23] . These studies showed that the highly conserved residues in SDRs are the key residues and suggested that a triad of residues, namely Ser-Tyr-Lys, forms the catalytic site in which tyrosine functions as the catalytic base, whereas serine stabilizes the substrate and lysine interacts with cofactor and lowers the pK a of the tyrosine. The conserved asparagine residue interacts with the active-site lysine residue via a water molecule to form a tetrad: Asn-Ser-Tyr-Lys [10, 17, 27] . Although the SDR family members share low (approx. 15-30 %) sequence identity, functionally important residues, such as catalytic sites (Asn-Ser-Tyr-Lys) and cofactor-binding motifs (Gly-Xaa 3 -Gly-Xaa-Gly), are highly conserved in the SDR family [9] [10] [11] 17] . The available 3D (three-dimensional) structures of SDRs have revealed relatively similar α/β folding patterns of a Rossmann fold [9, 10, 24, 25, 27] . Likewise, a number of studies had been carried out to investigate the cofactor specificities of the SDR family. The residues between the first β-sheet and the third α-helix of SDRs are potentially important determinants of the specificity of a cofactor towards either NADP(H) or NAD(H) [9, 19, 24, [28] [29] [30] [31] [32] [33] [34] . Furthermore, RoDHs have been shown to possess hydrophobic domains at the N-terminal and/or C-terminal regions, which may anchor the proteins into the membrane [11, [35] [36] [37] [38] [39] .
RDH10 (RDH class 10) was first cloned from bovine, mouse and human RPE [40] . The amino acid sequence homologies among RDH10 from different species are exceptionally high, with a 100 % identity between bovine and human RDH10 and a 99 % identity between mouse and human RDH10 at the amino acid level [40] . The highly conserved sequence of RDH10 across evolution suggests its functional significance. We also showed that RDH10 is predominantly localized in the microsomal fraction, similar to other membrane-bound RDHs [40] . A previous study showed that RDH10 is highly expressed in many other non-ocular tissues during forelimb and hindlimb differentiation, whereas other RDHs (RDH1, RDH5, RDH6, RDH7 and RDH11) have significantly lower expression than RDH10 at this stage [41] . Moreover, mice carrying a mis-sense mutation of RDH10 have an embryonic lethal phenotype, indicating an important role of RDH10 in the early embryonic development [42] . Furthermore, the lethal phenotype of this RDH10 mutant mouse can be rescued by RA treatment of the pregnant mother, suggesting that RDH10 is essential for RA generation at early stages of embryonic development [42] . Although its exact function in RA generation is uncertain, RDH10 is likely to function as the enzyme to convert atROL into atRAL, which is the substrate for Raldh2 to synthesize RA [2, 11] . This assumption is supported by a recent study showing that RDH10 and Raldh co-localize in tissues during embryogenesis and organ differentiation [43] .
To further study the structure and function of this important enzyme, the present study has characterized the conserved key residues in the predicted catalytic centre, cofactor-binding site and the membrane-association domain in RDH10.
EXPERIMENTAL

Alignment of amino acid sequences, hydropathy analysis and molecular modelling of RDH10
To predict key residues for the enzymatic activities of RDH10, amino acid sequences of human, mouse and rat RDH10 were aligned with human 17β-HSD-1 using the Clustal-W program in BioEdit (Ibis Therapeutics, Carlsbad, CA, U.S.A.). In order to define the hydrophobic domains of RDH10, the primary structure of human RDH10 was analysed using the Kyte-Doolittle scale program in BioEdit. On the basis of the known crystal structure of human 17β-HSD-1 (PDB no. 1EQU), a 3D structural model of human RDH10 was constructed using the Swiss Model optimize mode. Structural analyses were carried out using SwissPdb Viewer (http://www.expasy.ch/spdbv) and the resulting structures were displayed by the 3D rendering application POV-Ray version 3.61 (http://www.povray.org/).
Construction of human RDH10 expression vector and site-directed mutagenesis
The human RDH10 cDNA was subcloned into the pGEM-T easy vector (Promega, Madison, WI, U.S.A.). The site-directed mutants of predicted key residues in the catalytic centre, N169A, N169D, S197A, S197C, S197G, S197T, S197V, Y210A, Y210F, K214A and K214R, a triple mutant (G43A + G47A + G49A) of the three glycine residues in the predicted cofactor-binding 
motif (Gly-Xaa 3 -Gly-Xaa-Gly) and the deletion mutants of two potential hydrophobic domains, 2-23, 293-329, and a double deletion mutant in which both of the hydrophobic domains were deleted, were generated using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, U.S.A.), following the protocol recommended by the manufacturer. Primers used for the mutagenesis are summarized in Table 1 . The full-length cDNA sequences of the mutants were confirmed from both directions using ABI-3730 DNA sequencer (Applied Biosystems, Foster City, CA, U.S.A.) and subcloned into pcDNA6.1 vector (Invitrogen, Carlsbad, CA, U.S.A.). As a negative control, RFP (a red fluorescence protein, dsRed; Clontech, Mountain View, CA, U.S.A.) was amplified with additional restriction enzyme sites (NotI in a forward primer and HindIII in a reverse primer) and subcloned into the pGEM-T easy vector. The sequence of the cloned RFP cDNA was confirmed from both directions and subcloned into pcDNA3.1(−) (Invitrogen). After the sequence confirmations, the expression constructs were purified by QIAfilter Maxi Prep kit (Qiagen, Valencia, CA, U.S.A.). Furthermore, the purified expression constructs were transiently transfected into COS-1 cells using FuGENE ® 6 transfection reagent (Roche, Indianapolis, IN, U.S.A.). At 48 h after transfection, cells were harvested and expression of the gene was confirmed by Western blot analysis using an anti-RDH10 antibody [40] .
Western-blot analysis
Protein concentrations were measured by Bradford assay [44] . For Western-blot analyses, proteins were subjected to SDS/PAGE and electrotransferred on to a nitrocellulose membrane. The membrane was blocked with 5 % (w/v) nonfat dried skimmed milk in TBST {Tris-buffered saline [20 mM Tris/HCL (pH 7.6) and 137 mM NaCl] with Tween 20} for 30 min and subsequently incubated overnight at 4
• C with 1:1000 dilution of an anti-RDH10 polyclonal antibody [40] . After three washes with TBST, the membrane was incubated for 1 h with 1:6700 dilutions of a horseradish peroxidaseconjugated anti-rabbit IgG antibody (Vector Laboratories, Burlingame, CA, U.S.A.) in TBST containing 1 % non-fat dried skimmed milk. After four washes with TBST, the bands were detected using Western Lightning Chemiluminescence Reagent Plus (PerkinElmer, Boston, MA, U.S.A.) or Super Signal West Dura Extended Duration Substrate (Pierce, Rockford, IL, U.S.A.). As required the membrane was stripped using stripping buffer (Pierce) and re-blotted with an antibody specific for β-actin for a loading control. The bands (intensity × area) were semi-quantified by densitometry using GeneTools (SynGene, Frederick, MD, U.S.A.), results being an average from at least three independent experiments.
In vitro RDH activity assay
RDH activity assays were performed under dim red light. AtROL and atRAL (Sigma, St. Louis, MO, U.S.A.) were dissolved in DMF (dimethylformamide). For each assay, 31-125 μg of total membrane proteins of COS-1 cells expressing RDH10 and its mutants were added to 200 μl of reaction buffer (100 mM sodium phosphate, pH 7.4, containing 0.5 % BSA and 1 mM NADP + or NADPH). The reaction was started by the addition of atROL or atRAL in 2 μl of DMF. The final concentration of atROL was 0.7-11 μM and that of atRAL was 40-620 μM. After 30 min incubation, the reaction was stopped by addition of 300 μl of ice-cold methanol. Retinoids were extracted and separated by normal-phase HPLC as described previously [45] . The peak of each retinoid isomer was identified on the basis of the retention time of retinoid standards. For the activity assays of the deletion mutants of RDH10, the total cell lysates were incubated with NADP + and [11, H]atROL (1 mCi/ml; 45.5 Ci/mmol; American Radiolabeled Chemicals, St. Louis, MO, U.S.A.). The oxidizing activities of RDH10 mutants were calculated from the area of the atRAL peak using Radiomatic 610TR software (PerkinElmer). Elution peaks were identified by spiking with pure retinoid standards. The enzymatic activity was calculated from the area of the generated atRAL or atROL peaks using synthetic atRAL and atROL as standards for calibration. Kinetic parameters were calculated using the EnzFitter program (Biosoft, Cambridge, U.K.).
Subcellular fractionation of cultured cells
The COS-1 cells expressing wt (wild-type) RDH10 or the deletion mutants were harvested and washed twice with ice-cold PBS. Subsequently, cells were fractionated into cytosolic, membrane, nuclear and cytoskeletal (containing inclusion body) fractions using FractPrep TM (BioVision, Mountain View, CA, U.S.A.) following manufacturer's protocol. The same amount of proteins (0.5 μg for wt and 1 μg for mutants) from each fraction was resolved by SDS/10%-(w/v)-PAGE and analysed by Westernblot analyses using the antibody for RDH10 [40] to identify the subcellular localization of RDH10 or its mutants.
Determination of the favoured reaction catalysed by RDH10 in intact cells
The expression plasmids of RFP (negative control) and wtRDH10 were separately transfected into COS-1 cells. In order to eliminate the variation of transfection efficiency, the cells transfected with the same plasmid were trypsinized, pooled, seeded into the culture dishes at 18 h post-transfection and cultured for 24 h. Under the dim-red light, the cells were treated with 5 μM atRAL or 2 μM atROL in fresh Dulbecco's modified Eagle's medium containing 10 % FBS. The cells were harvested at 0, 1, 2, 3, 6, 12 and 24 h of the treatment and washed twice with icecold PBS. The cell pellets were lysed by sonication (power setting, 12 %; duration of bursts, 20s; Sonic Dismembrator model 500; Fisher Scientific, Pittsburgh, PA, U.S.A.) in 300 μl of the extraction buffer containing 50 % ethanol and 50 mM Mops, pH 6.0. Retinoids were extracted with 300 μl of hexane and analysed by HPLC as described above.
RESULTS
Replacements of conserved key residues in the predicted catalytic centre and the cofactor-binding motif do not significantly alter expression levels of RDH10
Human RDH10 was aligned with other well-characterized RDHs ( Figure 1A) , and potential key residues in the catalytic centre were predicted to be Asn 169 , Ser 197 , Tyr 210 and Lys 214 on the basis of sequence homology. Similarly, the conserved cofactor-binding motif was identified as Gly 43 , Gly 47 and Gly 49 . The structural model of RDH10 was predicted using homology modelling with 17β-HSD as a template. The predicted 3D structure retains the structural features of a Rossman fold consisting of seven parallel β-sheets surrounded by six parallel α-helixes ( Figure 1B) . Conserved key residues of RDH10 for the catalytic activity and cofactor binding were predicted at positions almost identical with those in 17β-HSD ( Figure 1C ). To confirm the roles of the predicted key residues, these residues were replaced with alanine or another residue with a side-chain structure similar to the native residue. To analyse the impact of these point mutations on the expression levels of the mutant proteins, the expression constructs of wtRDH10 and its mutants were transiently transfected into COS-1 cells and expression levels were measured by Westernblot analyses ( Figure 1D ). The conserved residue Ser 197 has been proposed to be a key residue responsible for stabilizing substrate in the catalytic centre of enzymes of the RDH family [10, 17] . We replaced Ser 197 with five different residues with different sizes of the side chain (S197A, S197C, S197G, S197T and S197V) to study the impacts of the side-chain size on the enzymatic activity. None of these mutants showed significant changes in protein expression levels compared with that of wtRDH10 after normalization using β-actin levels in the same blots ( Figure 1D ).
The enzymatic activity of RDH10 is abolished by most mutations of the predicted key residues in the catalytic centre and cofactor-binding motif wtRDH10 and its mutants were transiently expressed in COS-1 cells. The membrane fraction was isolated to eliminate endogenous cofactors and other cytosolic dehydrogenases possibly expressed in the cell line. The membrane fractions containing similar levels of RDH10 or its mutants ( Figure 2A) were incubated with atROL and the cofactor NADP + , and the produced retinoids were analysed by HPLC. The membrane containing wtRDH10 showed a substantially higher atRAL production than that of negative control (Figures 2B-2C) Figure S1 at http://www.BiochemJ. org/bj/419/bj4190113add.htm). Surprisingly, S197G and S197A mutants retained significant enzymatic activities, although lower than that of wtRDH10, whereas replacements of Ser 197 by cysteine, threonine and valine abolished the enzymatic activity of RDH10 (Figures 2D-2H) . Calculated kinetic constants, K m (μM) and V max (nmol/h per mg of protein) for atROL substrate were 4.1 and 3.35 for wtRDH10, 0.18 and 0.22 for S197A, and 1.1 and 0.74 for S197G mutants ( Table 2 ). The relative activities or catalytic efficiencies (V max /K m ) of S197A and S197G were 1.22 and 0.673 nmol · h −1 · mg −1 · μM −1 respectively, comparable with that of wtRDH10 (0.817 nmol · h −1 · mg −1 · μM −1 ), suggesting that these mutations did not result in significant changes in the RDH10 enzymatic activity.
Table 2 Kinetic parameters for wtRDH10 and its mutants
No activity was detected in the case of the following mutants: Nc (negative control), D169A, D169N, S197C, S197T, S197V, Y210A, Y210F, K214A, K214R and triple-glycine mutant. , wtRDH10 (C), S197A (D), S197C (E), S197G (F), S197T (G) and S197V (H). Peaks 1 and 2 indicate atRAL and atROL respectively.
Sequence domains responsible for membrane association of RDH10
Most RDHs possess at least one hydrophobic domain responsible for their membrane association [11, 12, [35] [36] [37] . Hydropathy analysis of the RDH10 sequence identified two potential hydrophobic domains: one at the N-terminus (residues 2-23) and the other near the C-terminus (residues 293-329) in human RDH10 ( Figure 3A) . The N-terminal domain was predicted as a transmembrane domain, whereas the C-terminal one, on the basis of hydrophobicity, may be a membrane-association domain ( Figure 3A ). To delineate which of these two regions is responsible for the membrane association of RDH10, these two regions were separately deleted to generate mutants 2-23, 293-329 and the double mutant lacking both of these regions. The proportions of these mutants in the membrane fraction were measured by cell-fractionation analysis. Different subcellular fractions were analysed by Western blotting using an antibody specific for RDH10, and RDH10 levels were semi-quantified by densitometry (Figures 3B-3F ). wtRDH10 was predominantly localized in the membrane fraction (except for those in inclusion bodies) (Figure 3B ), consistent with our previous findings [40] . The amounts of protein of the single deletion mutants, 2-23 and 293-329, in the membrane fraction were significantly decreased compared with that of wtRDH10 ( Figures 3B-3D ). However, in each of the single deletion mutants, there were still detectable proteins in the membrane, suggesting that deletion of one of the hydrophobic domains did not completely dissociate the protein from the membrane (Figures 3C and 3D ). In contrast, the double deletion mutant was completely dissociated from the membrane ( Figures 3E and 3F) . Since a significant amount of 2-23 and double deletion mutant proteins exist in the cytosolic fraction in vitro activity assays were carried out using total cell lysates. None of the deletion mutants showed any detectable enzymatic activities, whereas wtRDH10 exhibited significant oxidation of atROL to atRAL (Figures 3G-3K ).
In vitro measurement of the atRAL-reducing activity of wtRDH10 and its affinity for NAD cofactors
We examined whether wtRDH10 also catalyses the reduction of atRAL, as do many other RDHs. The membrane fraction of COS-1 cells expressing wtRDH10 was incubated with atRAL and NADPH. The membrane fraction from the cells expressing RFP did not show detectable reduction of atRAL, whereas a substantial amount of atROL was generated from atRAL substrate by RDH10 ( Figures 4A and 4B) , with K m and V max for atRAL of 570 μM and 65 nmol/h per mg of protein respectively (Table 3 ). This result indicates that RDH10 is an oxidoreductase similar to other RDHs and ADHs. Moreover, we performed another set of activity assays with various concentrations of the potential cofactors NADP + , NADPH, NAD + and NADH to calculate their affinities (K m ) to Table 3 ).
Determination of the favoured reaction catalysed by RDH10 in intact cells
Although the in vitro assays showed that RDH10 catalysed both oxidation of atROL and reduction of atRAL ( Figures 2 and 4) , it is unclear which is the favoured reaction catalysed by RDH10 under physiological conditions. To address this question, we performed further analysis to determine the reaction direction catalysed by RDH10 in intact cells. The COS-1 cells expressing wtRDH10 and those expressing RFP (negative control) were incubated with atROL or atRAL separately and harvested at various time points. The retinoids generated in the treated cells were analysed by HPLC. As shown in Figure 5 (A), both of the cells expressing RDH10 and the negative control cells expressing RFP generated substantial amounts of atROL from the atRAL substrate, suggesting existence of endogenous reductases. Actually, the cells expressing RDH10 showed a slightly lower activity in reducing atRAL into atROL, compared with the negative control (P < 0.05 at 12 and 24 h of incubation), suggesting that expression of RDH10 did not enhance the reduction in the cells. In contrast, the cells expressing RDH10 oxidized significantly higher amounts of atROL to atRAL in an incubationtime-dependent manner (P < 0.05 at all time points), whereas the negative control cells showed almost no detectable oxidation activity, suggesting RDH10 favours oxidation in intact cells as well as under in vitro assay conditions ( Figure 5B ).
DISCUSSION
RDH10 is an enzyme essential for generation of RA during embryonic development [42] . The primary structure of RDH10 is highly conserved across species, suggesting that it may have significant physiological functions [40] . However, the structure and function of this important enzyme have not been well investigated. The present study for the first time identified key residues in RDH10 essential for its enzymatic activity and sequence domains responsible for its membrane association. RDH10 belongs to the SDR family [40, 45] . The highly conserved four residues (asparagine, serine, tyrosine and lysine) in the catalytic centre and three glycine residues in the cofactorbinding motif (Gly-Xaa 3 -Gly-Xaa-Gly) have been shown to be essential for enzymatic activities in other members of the RDH family [9, 10, 17] . Sequence alignment with these known enzymes predicted that Asn 169 , Ser 197 , Tyr 210 and Lys 214 in RDH10 are potential key residues in the catalytic centre and that Gly 43 , Gly 47 and Gly 49 may constitute the cofactor-binding motif. To confirm the role of the potential key residues predicted on the basis of their sequence alignment, these predicted key residues were mutated using site-directed mutagenesis. Although these mutants did not show any significant change in RDH10 protein levels, the enzymatic activity assay demonstrated that single point mutations at Asn 169 , Ser 197 , Tyr 210 , Lys 214 and the tripleglycine mutations of the cofactor-binding motif abolished the enzymatic activity of RDH10, indicating that these residues are indeed essential for its enzymatic activity, but not for the protein stability. Current findings regarding enzymatic activity of RDH10 indicate that RDH10 retains all the key residues of the catalytic centre conserved in the RDH family and these residues are directly involved in the catalytic reaction of RDH10.
Filling et al. [17] proposed that Asn 111 (Asn 169 in RDH10) is part of a catalytic site highly conserved in SDRs, and replacement of asparagine by leucine in 3β-HSD abolished its activity. Our results with the Asn 169 mutants are consistent with this observation from 3β-HSD. In the 3D model of RDH10, however, Asn 169 is unlikely to have direct interactions with the other three residues in the catalytic centre. The role of Asn 169 in the enzymatic activity of RDH10 may be through interactions with the well-conserved residue Ser 213 (see Figures 1A) , which could serve as a bridge to connect Asn 169 to the catalytic centre (Ser-Tyr-Lys). On the basis of sequence alignment with other SDR family members (Ser 139 in DADH, Ser 142 in 17β-HSD-1 and Ser 138 in 3β-HSD), Ser 197 in RDH10 is considered important for stabilizing the substrate [10, 17] . It was reported that mutants of DADH with Ser 139 replaced by alanine or cysteine showed no detectable catalytic activities [16] . Similarly, replacement of serine at the corresponding positions in 17β-HSD-1 and 3β-HSD by cysteine, glycine and alanine abolished their catalytic activities [19, 22] , whereas mutant S138T in 3β-HSD showed an activity similar to that of the wt enzyme [17, 18] . Unlike those of previous studies, however, our results showed that the S197A mutant retained the enzymatic activity of RDH10, whereas the S197T mutant completely lost its activity. This disparity suggests that RDH10 is different from 3β-HSD in the structure of the substrate-binding pocket and substrate itself. Indeed, the S139A mutation in DADH abolished its enzymatic activity, whereas the S142A mutant of 17β-HSD-1 did not completely lose its catalytic activity [22] . This result supports our hypothesis that the mutations at the corresponding position may have slightly different impacts on the catalytic activity in different enzymes. The observation that replacement of Ser 197 by alanine or threonine generates differing impacts on its activity suggests that the size of the side chain of the amino acid at this position is important for its enzymatic activity.
Moreover, it was reported that there are three water molecules at a hydrogen-bond distance from the side chain of the catalytic triad; one of them, wat 107 , is present in accessible distance to OH group of Ser 138 . These water molecules are possibly significant for the proton-release steps in DADH catalysis, [24] . Likewise, a water molecule present near the NH group of Ser 142 in 17β-HSD-1 might play roles similar to wat 107 in DADH [25] . The cavity generated by substitution of Ser 197 by the residues with a smaller side chain (e.g. glycine and alanine) might be filled by an internal water molecule (wat 107 ) or other external water molecules from the outside of protein. Consistent with the 3D model analyses, our hypothesis is supported by the results that Ser 197 can be replaced by an amino acid with a single methyl group in the side chain without abolishing the activity of RDH10, whereas replacement of Ser 197 by residues with a larger side chain, such as cysteine, threonine and valine, may result in structural disturbance in the catalytic centre and, thus, affect the enzymatic activity of RDH10.
A number of studies have shown that the residues between the first β-sheet and the third α-helix of SDRs are important for its cofactor specificity [9, 24, [28] [29] [30] [31] [32] [33] [34] : (i) positively charged residues are present at the junction between the first β-strand (Asp 7 -Ala 12 in DADH) and the first α-helix (Gly 16 -Lys 27 ) (glycine-rich motif) and/or at the beginning of the third α-helix (Val 68 -Leu 82 ) [9, 24, 28] ; (ii) site-directed mutants D38N and A46R in DADH increased its cofactor specificity for NADP + [29, 30] ; (iii) the enzymes preferring NAD(H) possess an asparagine residue, whereas the NADP(H)-preferring enzymes have a positivecharged residue at the end of the second β-strand (position Asp 37 and Val 38 in 3α,20β-hydroxysteroid dehydrogenase) [31] [32] [33] [34] ; (iv) the site-directed mutants S12K and L36D of 17β-HSD-1 altered the cofactor specificity -the S12K mutant increased a preference for NADP(H), whereas L36D changed its cofactor preference from NADP(H) to NAD(H) [19] . On the basis of these criteria, RDH10 seems to be an NAD + -preferring enzyme, since RDH10 does not possess positively charged residues around the glycine-rich motif and an asparagine residue presents at the corresponding position, 37 (Asp 61 in RDH10). However, the present study showed that there is no significant difference in the binding constants of cofactors for RDH10, whereas other ROH enzymes show strict cofactor specificity with more than 1000-fold difference in cofactor binding constants {RalR1 (RDH11), 2700-fold [46] ; RDH12, 1800-fold [47] ; RDH13, 4000-fold [38] }. In general, the RDHs favouring NAD(H) are most likely to catalyse oxidations in vivo, and those favouring NADP(H) are most likely to catalyse reductions in vivo [12, 13] . However, some class-1 microsomal RDHs (RoDH1) from the rat liver [48, 49] and human retinol dehydrogenase in the epidermis (hRoDH-E2) [50] prefer NADP + as a cofactor to catalyse oxidation, as does RDH10 [12] . Similarly, another recent study showed that amphioxus retinol dehydrogenase-2 (BfRDH2) catalyses an NADH-dependent reduction of atRAL to atROL [39] . These findings support the contention that the cofactor preference does not necessarily constrain the direction of the reaction in RDH10 and some SDRs. When the conserved three glycine residues in the glycine-rich motif were replaced by alanine, the tripleglycine mutant completely lost its catalytic activity of RDH10, most likely due to the loss of the cofactor from the binding pocket. This indicates that the conformation of the glycine-rich motif itself is important for the cofactor binding. Replacement of Gly 14 in DADH by valine virtually inactivated the enzyme, whereas replacement by alanine retained 69 % of the wtDADH activity [51] . This result suggests that the structure of the glycinerich motif is essential for its catalytic activity and any structural disturbance can alter the enzymatic activity. Our present results revealed the significance of the glycine-rich motif in the co-factorbinding site.
Another common feature of RDHs is that most of the enzymes in this family are membrane-associated proteins [11, [35] [36] [37] . It was reported that RDHs are associated with the smooth endoplasmic reticulum and/or the microsomal membrane via hydrophobic anchors or transmembrane domains in the N-or C-terminus of RDHs [11, [35] [36] [37] . Previously we showed that RDH10 is predominantly expressed in the microsomal fraction of the RPE [40] . Sequence-hydropathy analysis predicts two hydrophobic domains in RDH10, one at the N-terminus and the other near the C-terminus. On the basis of the hydropathy plot, the N-terminal hydrophobic domain might form a transmembrane domain. To identify the mechanism for the membrane association of RDH10, these hydrophobic domains were deleted and the deletion mutants expressed in COS-1 cells. The subcellular localizations of the deletion mutants were compared with that of wtRDH10 by cell fractionation and Western blotting using an RDH10-specific antibody [40] . The subcellular fractionation showed that the deletion of a single hydrophobic domain did not completely abolish its membrane association, whereas deletion of both of these domains completely dissociated the protein from the membrane. These results suggest that both the hydrophobic domains of RDH10 contribute to its membrane-anchoring. Dissociation of RDH10 from the membrane abolishes its enzymatic activity, although the total protein levels are similar to that of wtRDH10. This result suggests that membrane association is essential for the enzymatic activity in RDH10 or for maintaining its native structure.
Similarly to what has been found for other RDH enzymes, our in vitro assay showed that RDH10 can catalyse reversible interconversion of retinoids in vitro, i.e. oxidation of atROL and reduction of atRAL. In our previous studies we did not detect significant reduction of atRAL to atROL catalysed by RDH10 [40] . The possible reason is that the concentration of the substrate used for the assay, 3 H-labelled atRAL, was substantially lower (0.1 μM) in our previous studies, compared with its K m , which is 570 μM, calculated from the present study. The present study showed that affinity of RDH10 for atROL (K m 4.1 μM) is 140-fold higher than its affinity for atRAL (K m 570 μM), suggesting that RDH10 favours oxidation at a lower concentration of substrate. Moreover, the calculated catalytic efficiency of RDH10 for atROL is 7-fold higher than that of atRAL. This further supports the notion that RDH10 favours oxidation. This suggests that atRAL is unlikely to serve as a substrate for RDH10 in vivo, since its K m is well above physiological concentrations of atRAL in tissues.
In the present study we have shown that the favoured reaction of RDH10 was oxidation, both in vitro and in intact cells. Oxidation of atROL in COS-1 cells expressing RDH10 was detectable and significantly higher than that of COS-1 cell expressing RFP as a negative control (see Figure 5 ), although the RDH10-expressing cells showed significantly lower interconversion of atRAL into atROL. This strongly suggests that RDH10 does not contribute to the reducing activity of atRAL in intact cells. On the basis of the in vitro kinetic data, this result is not surprising since the concentration of atRAL used was 5 μM, which is 114-fold less than the K m of RDH10 for atRAL. We therefore conclude that the favoured reaction of RDH10 is oxidation rather than reduction. On the basis of these results, it is possible that other RDHs reduce toxic atRAL into atROL under physiological conditions and, when necessary, atROL can be oxidized by RDH10 to generate atRAL, which is further oxidized to atRA by Raldh for retinoid signalling.
Although deficiency in some RDHs, such as RDH5 or RDH12, causes certain retinal dystrophies in human [8, 52, 53] , knockout of most RDHs did not show significant phenotypes, such as developmental defects or impaired vision in mice [54] [55] [56] [57] .
This strongly suggests that these RDH members have functional overlaps and can substitute for each other's functions. By contrast, RDH10 deficiency causes embryonic lethality in the mouse, suggesting that other RDH members cannot substitute for the function of RDH10 during the embryonic development. An important difference between RDH10 and other RDHs is its extremely high sequence homology across evolution, which supports the contention that RDH10 is functionally more significant than other RDH enzymes. RDH10 is likely to play an essential role in producing atRAL, which is the substrate for synthesis of RA at early developmental stages. The time course and regional transcriptional regulation of RDH10 expression has not been investigated. It is possible that RDH10 has the earliest expression among all of RDH enzymes and/or is expressed at the critical stages when the development and differentiation of the major organs occur.
